332: Pfizer's new R&D head, a VC deep-dive, and a new FDA commissioner?
The Readout Loud
00:00
Analyzing Investor Sentiment Amidst Political Shifts
This chapter explores the dynamics at a recent investor retreat, shedding light on the mood among pharmaceutical leaders during volatile political times. It delves into the implications of changing FDA regulations on market stability and drug approval, reflecting the industry's anxiety and uncertainty.
Transcript
Play full episode
